High‐dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high‐risk primary breast cancer
暂无分享,去创建一个
J. Doroshow | L. Leong | S. Akman | G. Somlo | S. Forman | K. Margolin | R. Morgan | J. Raschko | J. Harrison | C. Ahn | S. Nagasawa